SAGE Therapeutics (SAGE) – All Earnings Related News
-
SAGE Therapeutics (SAGE) Misses Q3 EPS by 69c
-
Sage, Biogen receive setback despite FDA approval of postpartum depression drug. This is why
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SAGE Stock Lookup